GLP-1 therapy is more than weight loss.
GLP-1 receptors are expressed throughout the body: brain, heart, liver, gut. The clinical implications extend well beyond the scale.

Physician-led GLP-1 care, refined over time.
Every Crimson GLP-1 protocol follows the same evidence-based structure.
Cardiometabolic Panel
Physician Review
Structured Titration
Retest & Act
Our protocol options.
Compounded and brand-name options. You choose the one that fits. Your physician reviews your intake and labs, confirms you are a candidate, and sets your starting dose.
Compounded medications are prepared by a licensed pharmacy for an individual patient. They are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness or quality. Choosing a product does not guarantee approval: your physician makes the final call on eligibility and your starting dose.
More than just weight loss.
GLP-1 medications are best known for weight loss, but GLP-1 receptors are also found in the heart, liver, brain, immune cells, and blood vessels. That is why GLP-1 therapy is being studied well beyond its original uses, and the research pipeline is among the most active in medicine.
In phase 3 trials of adults with obesity, average weight loss over 68 to 72 weeks was about 15% with semaglutide 2.4 mg and up to about 21% with tirzepatide 15 mg, compared with about 2 to 3% on placebo, alongside lifestyle changes. Individual results vary.
Common questions.
GLP-1 therapy is one of the most powerful tools in preventive medicine. Use it correctly.
Start with the recommended Cardiometabolic Panel. Confirm candidacy. Build the right protocol.






